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 Summary statement 
We identified a chondrocyte repertoire of lncRNAs and discovered that ROCR (regulator of 
chondrogenesis RNA) is important for MSC chondrogenesis and cartilage gene expression by 
promoting the expression of SOX9.  
 
Abstract 
Long non-coding RNAs (lncRNAs) are expressed in a highly tissue-specific manner where they function 
in various aspects of cell biology, often as key regulators of gene expression. In this study we 
established a role for lncRNAs in chondrocyte differentiation. Using RNA sequencing we identified a 
human articular chondrocyte repertoire of lncRNAs from normal hip cartilage donated by neck of 
femur fracture patients. Of particular interest are lncRNAs upstream of the master chondrocyte 
transcription factor SOX9 locus. SOX9 is an HMG-box transcription factor which is essential for 
chondrocyte development by directing the expression of chondrocyte specific genes. Two of these 
lncRNAs are upregulated during chondrogenic differentiation of MSCs. Depletion of one of these 
lncRNA, LOC102723505, which we termed ROCR (regulator of chondrogenesis RNA), by RNAi 
disrupted MSC chondrogenesis, concomitant with reduced cartilage-specific gene expression and 
incomplete matrix component production, indicating an important role in chondrocyte biology. 
Specifically, SOX9 induction was significantly ablated in the absence of ROCR, and overexpression of 
SOX9 rescued the differentiation of MSCs into chondrocytes. Our work sheds further light on 
chondrocyte specific SOX9 expression and highlights a novel method of chondrocyte gene regulation 
involving a lncRNA.  
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 Introduction 
Tens of thousands of long noncoding RNAs (lncRNAs) have been identified in the human genome 
through the use of RNA deep sequencing (RNA-Seq) (Iyer et al., 2015). lncRNAs are classified as >200nt 
RNAs that derive from both intergenic and overlapping protein-coding gene regions (Derrien et al., 
2012). Detailed studies are beginning to ascribe functional roles for many of these lncRNAs, which 
appear to regulate numerous cell processes (Rinn and Chang, 2012). Indeed, lncRNAs have emerged 
as key regulators of gene expression transcriptionally and post-transcriptionally, acting through 
diverse mechanisms such as the regulation of epigenetic modifications and by acting as scaffolds for 
protein complex formation at gene loci (Rinn and Chang, 2012). lncRNAs display more tissue-specific 
expression patterns than protein coding genes and cell differentiation during development is 
particularly susceptible to experimental loss of lncRNAs (Derrien et al., 2012; Sauvageau et al., 2013; 
Fatica and Bozzoni, 2014). For example, lncRNAs play important roles in guiding limb development. In 
limb patterning HOTTIP is required for specification of mesenchyme condensation sites through 
promotion of HOXA gene expression by a cis-regulatory mechanism, and HOTAIR is now also 
recognised for a similar trans-acting role in regulating HOXD gene expression during skeletal 
patterning (Wang et al., 2011; Li et al., 2013).  
Little is known about the expression of lncRNAs in cartilage or in the development of the chondrocyte, 
the sole cartilage cell type. Chondrocytes develop from condensations of mesenchymal cells in a 
process known as chondrogenesis, which is essential for development of the endochondral skeleton 
(Onyekwelu et al., 2009). During chondrogenesis cells of the mesenchyme commit to a chondrocyte 
differentiation program then progress through multiple stages to specify the resting, proliferating and 
hypertrophic regions of the growth plate. They also constitute the articular cartilage at the ends of the 
long bones. This differentiation is a coordinated process determined by temporal and spatial 
expression of multiple growth factors and dependent on the specific activity of the HMG-box 
transcription factor SOX9 (Akiyama, 2008). SOX9 controls the expression of numerous chondrocyte 
genes including its co-factors L-SOX5a and SOX6, and extracellular matrix genes such as type II collagen 
and the proteoglycan aggrecan. Experimental loss of SOX9 abrogates limb development in mice 
(Akiyama, 2008; Akiyama and Lefebvre, 2011) and mutations in the SOX9 coding sequence lead to the 
skeletal malformation syndrome campomelic dysplasia (CD) (Foster et al., 1994; Wagner et al., 1994). 
DNA alterations around the SOX9 locus can also lead to CD, highlighting the complex regulatory 
mechanisms governing SOX9 expression (Foster et al., 1994; Wagner et al., 1994). 
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SOX9 is found in a gene desert on chromosome 17, as is common for developmental transcription 
factors, surrounded by many potential regulatory regions. However, the cellular mechanisms for 
regulating SOX9 are not fully established. Analyses of campomelic dysplasia patient chromosomal 
rearrangements and promoter YAC transgenes suggest certain chondrogenesis-specific enhancers lie 
in a region between 50kb and 350kb upstream of SOX9 (Foster et al., 1994; Wagner et al., 1994; 
Wunderle et al., 1998; Gordon et al., 2009). SOX9 also specifies the fate of other lineages, including 
Sertoli cells, neural stem cells, pancreas progenitor cells and neural crest, neuronal, glial, heart valve, 
gut and kidney cells (Pritchett et al., 2011). Again tissue specific enhancers have been demonstrated 
to regulate the expression in some of these tissues (Gordon et al., 2009). 
cDNA cloning methods and in silico genome analysis have established that numerous ESTs and 
predicted transcripts are localised to these enhancer regions upstream of SOX9 but it is unclear which 
are expressed in particular tissues and whether any have a functional role in chondrocytes. We 
established a chondrocyte repertoire of lncRNAs and confirmed the presence of a number of 
transcripts around the SOX9 locus with whole transcriptome analysis of human articular cartilage RNA 
by RNA-Seq. We discovered a novel cartilage specific 4 exon lncRNA corresponding to a 3 exon RefSeq 
transcript LOC102723505 (Ensembl transcript ENST00000430908) 94kb upstream of SOX9, which we 
termed ROCR (Regulator of Chondrogenesis RNA). This lncRNA is required for successful 
differentiation of mesenchymal stem cells (MSCs) into chondrocytes where it appears to contribute 
to SOX9 expression. Thus, we have identified a previously unknown mechanism of SOX9 regulation 
involving a chondrocyte-specific lncRNA. 
 
 
Results 
RNA-Seq was performed on normal human hip articular chondrocyte RNA obtained from female neck 
of femur (NOF) fracture patients to establish the adult chondrocyte transcriptome and its complement 
of lncRNAs (6 samples; median age=76 years). Of the 46,087 transcripts identified (FPKM>1) 813 were 
annotated as lncRNAs (Supp. Table 2). Examination of cartilage RNA-Seq reads uploaded to the UCSC 
genome browser identified processed transcripts upstream of the SOX9 locus on chromosome 17, 
with robust expression of transcripts corresponding to SOX9-AS1 and LOC102723505 (Fig. 1A), 
exon/intron boundaries, and evidence of transcript start and end sites using CAGE (cap analysis gene 
expression) and PolyA-Seq data (Consortium, 2012; Flicek et al., 2014) (Supp. Fig. 1). Proximal to the 
SOX9 locus transcript variants of SOX9-AS1 were detected partially corresponding to Refseq and 
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predicted Ensembl transcripts. 94kb upstream of SOX9 we detected a novel 4 exon variant of an 
existing 3 exon RefSeq transcript LOC102723505. We designated 3 exon LOC102723505 as ROCR 
(regulator of chondrogenesis RNA) transcript variant 1 and the novel 4 exon isoform ROCR transcript 
variant 2. We noted the presence of chromatin features of actively transcribed genes such as histone 
H3 lysine 4 trimethylation (H3K4me3) at the presumed ROCR promoter and enhancer-like signatures 
based on histone lysine 27 acetylation (H3K27ac) states from ENCODE chromatin state data (Fig. 1A, 
Supp. Fig. 1) (Ernst et al., 2011). The ROCR locus is also notable for the expression of an additional 
lncRNA, LINC01152, albeit at very low levels in cartilage. In comparison with other coding transcripts 
SOX9-AS1 and ROCR were robustly expressed in cartilage with FPKM (Fragments Per Kilobase Of Exon 
Per Million Fragments Mapped) in the range of 5-15, approximately 10% of the level of SOX9 itself 
(Supp. Table 2). 
We confirmed the expression of SOX9-AS1 and ROCR in human articular cartilage by qRT-PCR with two 
assays per transcript targeted to different exons (Fig. 1B). The ROCR exon1-2 assay detects only 
transcript variant 2. Rapid amplification of cDNA ends (RACE) confirmed the presence of this novel 4 
exon 574-base ROCR transcript (variant 2) in cartilage (Supp. Fig. 2). We are also able to identify this 
ROCR variant by subsequent analysis of RNA-Seq data from knee cartilage RNA (Dunn et al., 2016). 
The majority of lncRNAs are considered to have nuclear functions and are often found enriched in the 
nucleus (Quinodoz and Guttman, 2014). In contrast to the nuclear enrichment of small nuclear RNA 
U2, we found both SOX9-AS1 and ROCR were enriched in the cytoplasm, comparable with the 
localisation of the SOX9 transcript itself (Fig. 1C). RNA-FISH analysis of ROCR in HAC was unsuccessful 
owing to the low expression and short transcript sequence limiting design of sufficient singly labelled 
Stellaris RNA-FISH probes (data not shown). In silico analysis indicates a lack of coding potential for 
both SOX9-AS1 and ROCR, with the existence of only very short open reading frames (ORF Finder) and 
codon substitution rates indicative of noncoding transcripts (CPAT, CPC and PhyloCSF) (Supp. Fig. 3). 
SOX9 is expressed in a variety of tissues but lncRNAs are reported to be more tissue specific (Derrien 
et al., 2012). Accordingly we examined expression of SOX9-AS1 and ROCR in additional joint tissues 
extracted from OA patients. SOX9-AS1 was also expressed in synovium and fat pad tissue but ROCR 
was largely undetected and may thus be specific to cartilage in the joint (Fig. 1D).  
We further examined transcript expression bioinformatically using publicly available cell and tissue 
RNA-Seq databases. Reads corresponding to SOX9-AS1 were found in numerous cells types in both 
Human Protein Atlas (http://www.proteinatlas.org/) and Illumina BodyMap (ArrayExpress accession: 
E-MTAB-513; http://www.ebi.ac.uk/arrayexpress) sequence data (Supp. Table. 3) (Consortium, 2012; 
Krupp et al., 2012; Fagerberg et al., 2014; Flicek et al., 2014). Reads corresponding to the 3 exons of 
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ROCR transcript variant 1 were found in pancreas and salivary gland tissue samples in the Human 
Protein Atlas RNA-Seq data and in breast tissue samples sequenced in the Illumina BodyMap data. 
Consistent with this analysis, further examination of expression by qRT-PCR across a 20-tissue RNA 
panel again identified the presence of SOX9-AS1 transcripts in a number of tissues (Fig. 1E), albeit less 
than SOX9 itself (Supp. Fig. 4). In contrast, detection of the novel ROCR transcript variant 2 was limited 
to chondrocytes alone (Fig. 1F), while the ROCR transcript variant 1 was additionally detected in brain 
and testis.  
Considering the proximity of these transcripts to SOX9 and the potential chondrocyte specificity of 
ROCR we sought to establish whether SOX9-AS1 and ROCR were regulated during chondrocyte 
development. Accordingly we characterised expression of these lncRNAs using a robust transwell MSC 
chondrogenesis method which produces a uniform cartilage disc with rapid and substantial induction 
of chondrocyte gene expression, albeit including the expression of chondrocyte hypertrophy genes, 
thus differing from articular cartilage (Fig. 2A) (Murdoch et al., 2007). SOX9 expression is upregulated 
during chondrogenesis. Similarly, the expression of both SOX9-AS1 and ROCR was induced during MSC 
chondrogenesis, paralleling the kinetics of SOX9 expression (Fig. 2 B-C). In contrast, LINC01152, a 
potential testis specific lncRNA (D43770 Genbank ID), was downregulated during MSC chondrogenesis 
(Fig. 2D) (Ninomiya et al., 1996). Interestingly, rapid amplification of cDNA ends (RACE) for MSC RNA 
identified a further 624-base isoform with an alternative first exon, which we termed ROCR transcript 
variant 3 (Supp. Fig. 1), situated in a bidirectional promoter locus with LINC01152.  
MSC are capable of tri-lineage differentiation into chondrocytes, osteoblasts and adipocytes, 
dependent on specific differentiation factors (Pittenger et al., 1999). We differentiated MSCs into 
osteoblasts and adipocytes by established methods and confirmed the expression of osteoblast 
specific markers alkaline phosphatase (ALPL) and RUNX2, and adipocyte specific genes adiponectin 
and FABP (Fig. 2E). SOX9 was not upregulated during osteoblastogenesis or adipogenesis (Fig. 2F). 
Similarly, SOX9-AS1 and ROCR were not upregulated during MSC osteoblastogenesis (Fig. 2G-H). SOX9-
AS1 was induced during MSC adipogenesis, in contrast to ROCR, but not to the level of chondrogenesis 
(Fig. 2G).  
SOX9-AS1 and ROCR were both upregulated during chondrogenesis, with a profile similar to SOX9, 
thus we addressed their potential role during MSC chondrogenic differentiation by specific RNAi-
mediated depletion (Fig. 3A). Reduction of SOX9-AS1 expression had no effect on development of a 
cartilaginous disc (Fig. 3B and C). However, depletion of ROCR prevented disc formation (Fig. 3B) and 
caused a significant reduction in wet mass (Fig. 3C). Consistent with the disruption of disc formation 
following ROCR RNAi, matrix deposition in the form of glycosaminoglycan (GAG) polyanions was also 
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reduced (Fig. 3D). In case the transwell chondrogenesis method was particularly susceptible to 
experimental manipulation we also performed the traditional pellet chondrogenesis method and 
again found that ROCR was required for pellet development (Fig. 3E). Analysis of extracted sulphated 
GAG levels again indicated that ROCR is required for matrix GAG production (Fig. 3F). In addition, ROCR 
depletion reduced DNA levels suggesting it was required for the MSC proliferation during the early 
stages of chondrocyte differentiation (Fig. 3G) (Murdoch et al., 2007). 
Examination of chondrocyte gene expression following SOX9-AS1 and ROCR RNAi indicated that 
depletion of ROCR also significantly abrogated the induction of cartilage ECM genes including COL2A1 
and ACAN (Fig. 4A). SOX9 is essential for cartilage matrix gene expression, so we assessed the impact 
of depletion of SOX9-AS1 and ROCR at earlier timepoints in the chondrogenesis timecourse. Following 
ROCR depletion SOX9 mRNA (Fig. 4B) and protein (Fig. 4C) was significantly reduced after 1 day of MSC 
differentiation and at even earlier time-points the upregulation of SOX9 expression during MSC 
chondrogenesis was lost following ROCR depletion suggesting a critical role for ROCR in SOX9 
induction. During chondrogenesis SOX9 is required for expression of SOX5 and SOX6 which 
subsequently cooperate with SOX9 in directing chondrocyte gene expression (Akiyama et al., 2002). 
ROCR depletion also prevented the upregulation of the SOX9 target genes SOX5 and SOX6, which 
occured after SOX9 induction (Fig. 4D).   
To complement the role identified by RNAi for ROCR in MSC chondrogenesis and SOX9 expression we 
also used an LNA GapmeR approach to deplete cellular ROCR levels (Supp. Fig. 5). Again the loss of 
ROCR resulted in a significant reduction in matrix GAG formation during MSC mini-pellet 
chondrogenesis with concomitant reduction in SOX9 and matrix gene expression (Supp. Fig. 5). ROCR 
transcript variants 2 (HAC) and 3 (MSC) were cloned and overexpressed in MSCs and HAC by lentiviral 
transduction (Supp. Fig. 6). Overexpression of ROCR had no effect on SOX9 expression or induction of 
cartilage ECM genes COL2A1 and ACAN during MSC chondrogenesis (Supp. Fig. 6A). Overexpression 
of ROCR had no effect on SOX9 expression in HAC (Supp. Fig. 6B). 
The above data suggested that ROCR is important for MSC chondrogenesis. We sought to establish 
whether the role of ROCR was specific to chondrocyte development consistent with its restricted 
expression profile. Accordingly we also performed SOX9-AS1 and ROCR RNAi during MSC 
osteoblastogenesis and adipogenesis. Depletion of ROCR during osteoblast differentiation caused a 
partial decrease in matrix mineralisation (Fig. 5A and quantified in Fig. 5B), but no significant impact 
on RUNX2 or ALPL expression (Fig. 5C). During MSC adipogenesis ROCR depletion had little effect, 
whereas SOX9-AS1 depletion partially reduced fat droplet generation (Fig. 6D and quantified in Fig. 
5E) and significantly decreased MSC adipogenic gene expression (Fig. 5F). 
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SOX9 is essential for chondrogenesis and since lncRNAs can contribute to the expression of 
neighbouring genes (Vance and Ponting, 2014) we reasoned the primary role of ROCR is to promote 
SOX9 expression. Accordingly overexpression of SOX9 would be expected to rescue the 
chondrogenesis impairment caused by ROCR depletion. Lentiviral overexpression of SOX9 successfully 
enhanced MSC chondrogenesis (Fig. 6A-B). By overexpressing SOX9 and thereby returning the levels 
of SOX9 to those of control (Fig. 6C) the significant reduction of cartilage matrix GAG levels following 
depletion of ROCR was almost fully reversed (Fig. 6D). Reduction of COL2A1 and ACAN by ROCR 
depletion was partially reversed by overexpression of SOX9 (Fig. 6E-F), while the levels of L-SOX5a and 
SOX6 were completely rescued (Fig. 6G-H). 
 
Discussion 
In this study we established a panel of lncRNAs in normal human articular cartilage and identified two 
transcripts upstream of the SOX9 locus that were upregulated during MSC chondrogenesis. One of 
these, ROCR, is a functional cartilage-restricted lncRNA which appeared important for chondrocyte 
differentiation where it may facilitate the induction of SOX9 itself. This study established that a lncRNA 
contributes to SOX9 expression during differentiation of MSCs into chondrocytes thereby furthering 
our understanding of the key regulatory elements contained upstream of the SOX9 promoter. 
SOX9 is the master transcription factor governing chondrocyte development, as confirmed by genetic 
studies (Akiyama et al., 2002). Regulation of SOX9 occurs at both the transcriptional and post-
transcriptional level. Phosphorylation of SOX9 regulates its DNA binding activity and subcellular 
localisation, and numerous other interactions regulate SOX9 stability and facilitate its transcriptional 
activity (Kawakami et al., 2006; Akiyama, 2008). At the transcriptional level induction of SOX9 occurs 
rapidly during mesenchyme condensation in cartilage development both in vivo and in vitro (Wright 
et al., 1995; Sekiya et al., 2002), a process regulated by an interplay between growth factor signals 
and cell-cell interactions (Chimal-Monroy et al., 2003; Yoon et al., 2005). Our data indicated that 
during in vitro chondrogenesis a lncRNA, ROCR, is also important for this process.  
A number of lncRNAs have key roles in stem cell differentiation, including RMST in neuronal 
differentiation, Braveheart in cardiac differentiation and lnc-RAP1-10 in adipocyte differentiation 
(Klattenhoff et al., 2013; Ng et al., 2013; Perry and Ulitsky, 2016). Previously identified lncRNAs with 
a potential role in cartilage development include DA125942 and LncRNA-HIT (Maass et al., 2012; 
Carlson et al., 2015). DA125942, a lncRNA transcribed from the CISTR-ACT locus interacts in cis with 
PTHLH and trans with SOX9 to organise chromatin structure and promote transcription in cartilage 
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(Maass et al., 2012). No direct role for the lncRNA in chondrogenesis was explored although the 
lncRNA locus was active during mouse limb bud development. LncRNA-HIT, expressed in mouse limb 
mesenchyme from the Hoxa gene locus, is able to bind and regulate DNA regions surrounding a 
number of cartilage genes including the Hoxa genes themselves (Carlson et al., 2015). LncRNA-HIT may 
activate gene expression by binding to p100/CBP and it contributes to micromass chondrogenic 
differentiation of murine MSCs. Interestingly, we detected no RNA expression from the CISTR-ACT 
locus in our human cartilage RNA-Seq data and the conserved regions of LncRNA-HIT in human 
corresponded to an isoform of HOXA13 with an extended 3’UTR rather than a lncRNA. It is possible 
these lncRNAs may be developmental stage or MSC specific. lncRNA DANCR may also promote 
chondrogenic differentiation of synovium-derived MSCs in concert with SOX4 (Zhang et al., 2015). Two 
recent reviews elaborate on the roles of these lncRNAs during chondrogenesis (Huynh et al., 2017; 
Lefebvre and Dvir-Ginzberg, 2017). 
SOX9 is located in a ~2Mb gene desert on chromosome 17 in humans and lncRNA ROCR is expressed 
from a locus 94kb upstream of SOX9. Chromosomal rearrangements within this region are associated 
with campomelic dysplasia (CD), a skeletal malformation syndrome, and Pierre Robin sequence (PRS), 
a craniofacial disorder. Such disruptions can occur in regions up to and greater than 1Mb upstream of 
SOX9 (Gordon et al., 2009). Characterisation of these DNA alterations has indicated the presence of 
enhancer regions linked to the regulation of SOX9 expression. Breakpoints causing more severe forms 
of CD are found more proximal to SOX9 at locations 50-375kb upstream (Leipoldt et al., 2007). 
Transgene and reporter experiments have also indicated that sequences in these locations are able to 
drive gene expression in vivo (Gordon et al., 2009). More recent analysis confirmed the presence of a 
murine enhancer element at -70kb (-62kb in human) capable of regulating SOX9 expression in a 
number of tissues (Mead et al., 2013), and three further enhancers with prominent activity in 
chondrocytes at -84kb, -195kb and -250kb in mice (Yao et al., 2015).  
The ROCR locus sits within these enhancer regions and it is attractive to suggest that the lncRNA may 
contribute to the regulation of SOX9 in vivo. Indeed functional lncRNAs have been found to be 
enriched in genomic regions surrounding key developmental transcription factors (Orom et al., 2010; 
Ulitsky et al., 2011). In addition to skeletal malformations patients with CD often show XY sex reversal, 
with additional clinical features such as hearing loss, developmental delay, and occasional heart 
defects (Mansour et al., 2002). Consistent with this, genetic ablation of Sox9 in mice disrupts the 
differentiation of cells in the heart, central nervous system, testis, pancreas, gut and inner ear (Gordon 
et al., 2009). Tissue specific enhancers regulate the expression of SOX9, for example the testis 
enhancer TES at -10kb, and our analysis suggested that ROCR is restricted to certain cell types: 
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cartilage, brain and testis, while ROCR variant 2 was only detected in cartilage. However our work 
focussed on RNA extracted from aged NOF and OA tissue and further work is required to confirm the 
expression of ROCR in normal healthy tissues. In combination with tissue specific enhancers ROCR may 
be required for the tightly coordinated spatio-temporal expression of SOX9 during development. The 
expression level of SOX9 in cartilage was 1-2 orders of magnitude higher than other tissues (Supp. Fig. 
4) and we reasoned ROCR might also contribute to the magnitude of SOX9 expression. But, in contrast 
to its role in chondrogenesis, we found no significant contribution by ROCR to SOX9 expression levels 
in adult articular chondrocytes (Supp. Fig. 7A). The role of ROCR in SOX9 expression might be in 
response to cues during chondrogenesis that are not present in cultured HAC and ROCR may 
additionally regulate other genes/proteins. The induction of both SOX9-AS1 and ROCR paralleled the 
expression of SOX9. The activity of the aforementioned -70kb, -84kb and -195kb SOX9 upstream 
enhancers is dependent on SOX9 in differentiated chondrocytes (Yao et al., 2015). Prior to the onset 
of chondrogenesis SOX9 overexpression in MSCs didn’t significantly induce ROCR expression (Supp. 
Fig. 7B), but we can’t rule out that SOX9 may promote the expression of ROCR during chondrogenesis, 
or in adult chondrocytes. Despite knockdown of ROCR reducing SOX9 expression and cartilage gene 
expression in MSCs reciprocal overexpression of ROCR had no effect. Overexpression from an artificial 
plasmid transcription start site is not entirely analogous to endogenous ROCR expression with 
potential alteration to secondary structure formation and cellular localisation of the RNA. 
During skeletogenesis MSC condensation initiates the formation of multipotent 
osteochondroprogenitors whose lineage fate is then determined by the combination of growth factor 
signals received. ROCR is only upregulated during chondrogenesis, not osteoblastogenesis, suggesting 
a key role in directing MSCs toward the chondrocyte lineage. Consistent with this only a minor impact 
of ROCR depletion was observed during MSC osteoblastogenesis in contrast to its key requirement 
during chondrogenesis. During osteochondroprogenitor differentiation SOX9 has antagonistic effects 
on the osteoblast transcription factor RUNX2 in determining the specific differentiation into their 
respective chondrocyte and osteoblast lineages (Zhou et al., 2006). Owing to the lack of induction of 
ROCR during osteoblastogenesis, no effect would be expected. Interestingly, depletion of SOX9-AS1 
significantly reduced the expression of adipogenic marker genes, confirming the efficacy of the SOX9-
AS1 depletion and given the role of SOX9 in adipogenic differentiation suggests SOX9-AS1 also 
contributes to the differentiation (Stockl et al., 2013).  
We demonstrated that returning SOX9 levels to normal by overexpression could reverse the impaired 
chondrogenesis phenotype caused by depletion of ROCR. This indicated that SOX9 can largely replace 
ROCR during MSC chondrogenesis as SOX9 expression was sufficient to produce the cartilage matrix. 
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Thus, suggesting ROCR is indirectly needed in chondrogenesis to establish the correct level of SOX9 
expression in MSCs during differentiation. Both silencing and activating roles have been demonstrated 
for lncRNAs. XIST establishes X chromosome inactivation, while RMST facilitates SOX2 binding to 
promoter regions of neurogenic transcription factors (Vance and Ponting, 2014). In some cases 
enhancer regions and the process of transcription at the lncRNA locus facilitate downstream gene 
expression rather than the lncRNA transcript itself (Engreitz et al., 2016). Our knockdown experiments 
indicate that ROCR transcript is functional, and the ROCR locus is considerably upstream from SOX9 
(94kb), but we can’t rule out that the ROCR locus may also function as an enhancer. Many of the 
identified functional lncRNA actions occur in the nucleus, however, ROCR appears to reside more in 
the cytoplasm than nucleus, indicating an indirect regulation of SOX9. Our coding analysis indicated 
ROCR is unlikely to code for any significant peptide transcript suggesting a role for the RNA in the 
cytoplasm. A number of cytoplasmic lncRNAs can regulate mRNA half-life and translation. TINCR is 
induced during epidermal differentiation and required for stability of differentiation mediators (Kretz 
et al., 2013) and antisense Uchl1 lncRNA promotes translation of Uchl1 (Carrieri et al., 2012). Other 
factors also contribute to cartilage gene expression, such as SP1 and forkhead/winged-helix domain 
(FOX) proteins, and may account for why despite normal GAG levels, the expression of COL2A1 and 
ACAN was not completely restored during rescue by SOX9, again suggesting an indirect effect of ROCR 
(Liu et al., 2016). Or this may simply reflect the difference in sampling time for gene expression in 
comparison to matrix GAG measurement. Almost all lncRNAs function through association with 
protein partners and accordingly RNA pulldown methods are commonly used to identify such 
interactions (Yang et al., 2015).  
Conservation of lncRNAs across species is low, with less than 10% of all lncRNAs exhibiting regions of 
conservation compared to random control regions (Iyer et al., 2015), but there are key examples of 
conserved lncRNAs with critical roles in mouse development having human counterparts (Sauvageau 
et al., 2013). By homology search for a mouse orthologue of ROCR we identified a predicted noncoding 
RNA transcript (NR_024085/BC006965) with sequence similarity to exon 2 of ROCR transcript variant 
1 (exon 3 of variants 2 and 3), but little mammalian sequence conservation in general (Supp. Fig. 8). 
Importantly, the transcripts are in syntenic regions (containing SOX9) of human chromosome 17q24 
and mouse 11qE2. By real-time RT-PCR of mouse cartilage RNA we have now confirmed the expression 
of a murine multiple exon version of ROCR (Supp. Fig. 8). Further work will establish whether the 
murine transcript is regulated during chondrogenesis and contributes to chondrocyte development.  
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Conclusions 
The cartilage transcriptome contains many lncRNA transcripts many of which may have important 
functions in cartilage biology. Our identification of cartilage lncRNAs complements the previous 
identification of inflammation-induced lncRNAs in chondrocytes (Pearson et al., 2016). This panel of 
chondocyte lncRNAs is specific to human aged hip cartilage and further work should establish the 
expression of lncRNAs specific to different zones of articular cartilage, as well as growth plate cartilage 
and to establish the impact of weight bearing, age and disease such as OA. Functional analysis 
indicated that ROCR was induced during chondrogenic differentiation and played an important role in 
the induction of SOX9 and as a result cartilage gene expression. Because SOX9-expressing cells are 
progenitors for numerous tissues identifying chondrocyte-specific regulatory elements might aid 
understanding of differentiation of chondrocytes from MSCs, potentially useful in chondrocyte tissue 
engineering applications. 
  
Methods 
Human tissue isolation 
Normal human articular cartilage was obtained from patients undergoing joint replacement surgery 
due to intracapsular neck of femur fracture (NOF). OA human articular cartilage was obtained from 
knee joint replacement operations on patients diagnosed with osteoarthritis (OA). Synovium and 
infrapatellar fat pad were also collected from the knee of OA patients. All tissue was obtained with 
informed consent and ethics committee approval from the Newcastle and North Tyneside Health 
Authority. Scoring, extraction and patient information for the NOF samples are detailed in Xu et al. 
(Xu et al., 2012). Briefly, joints were inspected macroscopically and scored by blinded experience 
orthopaedic surgeon to identify normal NOF cartilage. Cartilage, all zones, was collected within 2 hours 
of surgery stored at −80°C prior to RNA extraction.  
Human bone marrow MSC culture 
Human bone marrow MSCs (from seven donors, 18-25 years of age) were isolated from human bone 
marrow mononuclear cells (Lonza Biosciences, Berkshire, UK) and cultured and phenotype-tested as 
described previously (Barter et al., 2015). Experiments were performed using cells between P2-P7, 
and all experiments were repeated with cells from 3-4 donors. 
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 Chondrogenic differentiation 
MSC were resuspended in chondrogenic culture medium consisting of high glucose DMEM containing 
100 µg/ml sodium pyruvate, 10 ng/ml TGF-β3, 100 nM dexamethasone, 1x ITS-1 premix, 40 µg/ml 
proline, and 25 µg/ml ascorbate-2-phosphate. 5x105 MSC in 100µl medium were pipetted onto 6.5mm 
diameter, 0.4-µm pore size polycarbonate Transwell filters (Merck Millipore, Watford, UK), 
centrifuged at 200g for 5 minutes, then 0.5 ml of chondrogenic medium added to the lower well as 
described described previously (Murdoch et al., 2007; Barter et al., 2015). For V-bottom 96-well plate 
pellet chondrogenesis 5x104 MSCs in 150µl chondrogenic medium were pipetted into a UV-sterilised 
V-bottom 96-well plate and centrifuged at 500 g for 5 minutes. Media were replaced every 2 or 3 days 
for up to 7 days. 
Osteoblast and adipocyte differentiation 
MSC were plated in 96-well plates at a density of 15000/cm2 for 24 hours then media were replaced 
with either osteoblastogenic culture medium consisting of DMEM supplemented with 10% FBS v/v 
(foetal bovine serum), β-Glycerol Phosphate (10mM), dexamethasone (100nM) and ascorbic acid 2-
phosphate (50ug/ml), or adipogenic culture medium consisting of DMEM supplemented with 10% 
FBS, dexamethasone (1μM), insulin (10μg/ml), IBMX (0.5mM), indomethacin (60μM), rosiglitazone 
(2μM) and IGF-1 (20nM; R&D Systems) (all Sigma unless specified). Media were replaced every 3 or 4 
days. 7 days of differentiation was sufficient to assess gene expression changes in markers of 
differentiation. Cells were cultured for 21 days in osteoblastogenic medium to achieve fully 
mineralized cultures, and for 14 days in adipogenic medium for lipid production.  
Histology and biochemical analysis 
Transwell discs were stained as described (Barter et al., 2015). Chondrogenic pellets and transwell 
discs were digested with papain (10U/ml) at 60°C (Murdoch et al., 2007). The sulphated 
glycosaminoglycan (GAG) content was measured by 1,9-dimethylmethylene blue binding (Sigma) 
using chondroitin sulphate (Sigma) as standard (Farndale et al., 1982), and the DNA content was 
measured with PicoGreen (Invitrogen) intercalating dye following the manufacturer’s instructions. 
Cells undergoing osteoblast differentiation were fixed in 70% cold EtOH (5 minutes, -20°C). After 
drying the wells to reveal calcium-rich mineralisation deposits the cells were incubated at room 
temperature with a solution of Alizarin Red (Sigma) (40 mM, pH 4.2) for 20-30 minutes. For 
quantification the staining was extracted with 10% (w/v) Cetylpyridinium (Sigma) solubilized in 10 mM 
sodium phosphate buffer (pH 7) and the absorbance measured at 620nM. Cells undergoing 
adipogenesis were fixed with formalin for 1 hour, washed with distilled water and 60% isopropanol 
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then dried. To reveal the presence of lipid droplets the cells were stained with a 21% (w/v) solution of 
Oil Red O for 10 minutes. For quantitation the staining was extracted with 100% isopropanol and the 
absorbance measured at 500nM. Stained cells were washed with distilled water prior to image 
acquisition. 
RNA extraction and real-time reverse transcription PCR 
Cartilage, synovium and fat pad samples were ground into powder and homogenized using Invitrogen 
TRIzol Reagent (Life Technologies, Paisley, UK) prior to RNA purification using the Qiagen RNeasy mini 
kit (Qiagen, Crawley, UK) essentially as previously described (Xu et al., 2012). MSC chondrogenic 
transwell discs were disrupted in TRIzol (for real-time RT-PCR) using a small disposable plastic pestle 
and an aliquot of Molecular Grinding Resin (G-Biosciences/Genotech, St. Louis). MSC chondrogenesis 
pellets were disrupted in Ambion Cells-to-cDNA II Cell Lysis buffer (Life Technologies). Total RNA was 
then extracted and converted to cDNA using MMLV reverse transcriptase (Invitrogen) and TaqMan 
real-time RT-PCR was performed and gene expression levels were calculated as described previously 
(Barter et al., 2010). Nuclear and cytoplasmic RNA fractions were separated using the CelLytic 
NuCLEAR Extraction Kit (Sigma) supplemented with RNaseOUT ribonuclease inhibitor (Life 
Technologies). All values are presented as the mean ± SEM of replicates in pooled experiments. lncRNA 
real-time RT-PCR amplification products were sequence verified by cloning into the pCR4-TOPO vector 
(Life Technologies). Ambion FirstChoice Human Total RNA Survey Panel (AM6000) contains pools of 
total RNA from 20 different normal human tissues, each pool consisting of RNA from at least 3 tissue 
donors. Primer sequences are located in Table 1. 
RNA-Seq and analysis 
RNA integrity was checked using an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, 
California); RNA samples with an RNA Integrity Number (RIN) ≥ 7 were selected. For each sample cDNA 
libraries were prepared for sequencing from 5µg of total RNA using Illumina TrueSeq mRNA kits with 
the manufacturers’ protocols. mRNA enriched RNA was initially purified using polydT oligo attached 
magnetic beads using two rounds of purification. During the second elution the RNA was fragmented 
and random primed for cDNA synthesis. After the addition of a single ‘A’ base adaptors were annealed, 
and the products purified and enriched with PCR to create a final cDNA library. No indexing (barcoding) 
was performed.  Library DNA size was checked using the Agilent Bioanalyzer and quantified using the 
Kapa Library Quant kits (Kapa Biosciences). A 7.5pM solution of each library was loaded onto each 
lane of an Illumina Genome Analyzer IIa and 78-base paired-end sequencing performed. On average 
each sample gave 28 million read pairs. Sample quality control was performed using FastQC 
(Babraham Bioinformatics). Reads were aligned to the reference genome using TopHat, specifying 
mate inner distance (mean inner distance between mate pairs) and standard deviation for each 
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sample (Trapnell et al., 2012). Mapped reads were then assembled into complete transcripts using the 
splice junction mapping tool Cufflinks, with option –G which utilises the Ensembl reference gene track 
to improve mapping. Cuffmerge was used to merge the assembled transcripts into a consensus gene 
track from the all of the mapped samples. Ensembl transcript biotypes were applied to identify 
lncRNAs (biotype lincRNA). Coding potential of lncRNAs was assessed with ORFfinder (NCBI), Coding 
Potential Assessment Tool (CPAT), Coding Potential Calculator (CPC) and PhyloCSF (Kong et al., 2007; 
Lin et al., 2011; Wang et al., 2013). RNA sequencing has been uploaded to GEO. 
RNA-mediated interference, GapmeR transfection and lentiviral transduction 
For siRNA transfection 50nM siRNA was transfected into 40-50% confluent MSCs using DharmafectTM 
1 lipid reagent (Thermo Fisher). 50nM siRNA Dharmacon siGENOME and ON-TARGET+ siRNA (Thermo 
Fisher Scientific, Lafayette, CO.) were used to target SOX9-AS1 and ROCR. Depletion of gene-specific 
mRNA levels was calculated by comparison of expression levels with cells transfected with 50nM 
siCONTROL (non-targeting siRNA 2, cat. 001210-02; Dharmacon). For GapmeR transfection 100nM 
Antisense LNA GapmeR (Exiqon, Vedbaek, Denmark) targetting ROCR or non-targetting control 
(Negative Control A, cat. 300610) were transfected as for siRNAs. siRNA and GapmeR sequences are 
located in Table 1. pCDH-EF1-MCS-IRES-copGFP lentivirus expression vector (System Biosciences, Palo 
Alto, CA) containing SOX9 was generated by cloning SOX9 from pUT-FLAG-SOX9 (Lefebvre et al., 1997). 
pCDH-EF1-MCS lentivirus expression vectors containing ROCR transcript variant 2 and transcript 
variant 3 were generated by cloning gBlock gene fragments (IDT) containing the sequences specified 
in Supp. Fig 1. Lentiviruses expressing SOX9, ROCR or control empty vector lentivirus were generated 
by transfecting HEK-293T cells with pCDH plasmids, together with packaging plasmids pCMV-VSV-G 
and psPAX2 (Addgene #8454 and #12260). The virus-containing culture media were collected every 
24 hours for 3 days and concentrated (10x) with Clontech Lenti-X Concentrator into PBS (Takara, 
Mountain View, CA). MSCs and HAC were transduced with the lentivirus-containing PBS plus 8 μg/ml 
polybrene. A Promega CytoTox 96 cytotoxicity assay was used to assess cell viability following siRNA 
treatment (Supp. Fig. 8). 
Rapid amplification of cDNA ends (RACE) 
5’RACE was performed on RNA extracted from human articular cartilage or MSCs using the Invitrogen 
5' RACE System for Rapid Amplification of cDNA Ends (Life Technologies). Primer sequences are listed 
in Supp. Table 1. PCR amplification products were electrophoresed on agarose gels, cloned into the 
pCR4-TOPO vector and Sanger sequenced. The sequences have been uploaded to GenBank. 
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Immunoblotting 
Lysates from MSCs were prepared as described previously (Barter et al., 2010). Lysates were 
immunoblotted with the following antibodies: SOX9 (AB5535, 1:2000 dilution) and GAPDH (AB2302, 
1:40000 dilution) (both Merck Millipore). Secondary anti-rabbit antibodies were from Dako (Ely, UK) 
and chemiluminescent images were captured using a G:BOX Chemi system (Syngene, Cambridge, UK). 
Statistical analysis 
Data from each donor was individually analysed for gene expression and the values from each donor 
were then pooled to generate the mean± SEM. Significant differences between sample groups were 
assessed by one-way analysis of variance followed by the Bonferroni post hoc test for multiple 
comparisons or a two-tailed Students t-test was performed for single comparisons. 
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 Figure 1. Expression of lncRNAs from the SOX9 locus 
A. UCSC genome browser schematic of cartilage RNA-Seq reads aligned to the human genome with 
RefSeq gene annotations, Ensembl gene predictions and active H3K27Ac chromatin marks. Reads are 
pooled from 6 neck of femur (NOF) fracture cartilage donors. Primer locations are indicated by red 
arrowheads. B. Expression of SOX9 locus lncRNAs and SOX9 in RNA extracted from OA cartilage 
measured by real-time RT-PCR normalised to 18S. Values are the mean ± SEM of data pooled from 5 
separate donors. C. Subcellular localisation of SOX9-AS1 and ROCR in comparison with small nuclear 
RNA U2 and SOX9 mRNA pooled from 2 OA HAC donors. Values are the mean ± SEM of ΔCT between 
an equal fraction of nuclear and cytoplasmic RNA. D. Expression of SOX9-AS1 and ROCR in RNA 
extracted from OA synovium and joint fat pad. Values are the mean ± SEM of data pooled from 8 
separate synovium and fat pad donors. E. Expression of SOX9-AS1 and ROCR in an RNA tissue panel 
measured. Values are the technical mean of data pooled from 3 donors per tissue. 
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 Figure 2. Expression of lncRNAs during MSC differentiation 
A. Expression of the indicated genes in RNA extracted from MSCs undergoing chondrogenic 
differentiation at the indicated timepoints between Day 0 and Day 7. B-D. Expression of (B) SOX9-AS1, 
(C) ROCR and (D) LINC01152 during MSC chondrogenic differentiation. E. Expression of the indicated 
genes in RNA extracted from MSCs undergoing osteoblastogenic and adipogenic differentiation. F-H. 
Expression of (F) SOX9, (G) SOX9-AS1 and (H) ROCR during MSC osteoblastogenic and adipogenic 
differentiation. Values are the mean ± SEM of data pooled from 3-4 MSC donors.  
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 Figure 3. Effect of lncRNA depletion on MSC chondrogenic differentiation 
A-D. MSCs were transfected for 2 days with SOX9-AS1 or ROCR-targetting or non-targetting control 
siRNA prior to chondrogenic differentiation in hanging transwell inserts. A. SOX9-AS1 and ROCR 
expression in RNA extracted from Day 3 and Day 7 chondrogenic discs. Expression is presented as a 
percentage of non-targetting control levels. B. Representative Day 3 and 7 chondrogenic discs. C. Wet 
mass of Day 7 chondrogenic discs. D. Representative Safranin O staining of Day 7 chondrogenic discs. 
E-F. MSCs were transfected for 1 day with ROCR-targetting or non-targetting control siRNA prior to 
chondrogenic differentiation in a V-bottom 96 well plate. E. Representative Day 7 chondrogenic 
pellets. F. GAG levels assayed by DMB assay in Day 7 chondrogenic pellets. G. DNA quantification by 
PicoGreen assay in Day 7 chondrogenic pellets. Values are the mean ± SEM of data pooled from (A-D) 
3 MSC donors; (E-F) 4 MSC donors. ∗ = P < 0.05; ∗∗∗ = P < 0.001 for lncRNA siRNA versus non-targetting 
siRNA. Significant differences between sample groups were assessed by one-way analysis of variance 
followed by the Bonferroni post hoc test for multiple comparisons or a two-tailed Students t-test was 
performed for single comparisons. 
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 Figure 4. Effect of lncRNA depletion on MSC chondrogenic gene expression 
A. MSCs were transfected for 2 days with SOX9-AS1 or ROCR-targetting or non-targetting control 
siRNA prior to chondrogenic differentiation in hanging transwell inserts. RNA was extracted and 
expression of the indicated genes measured by real-time RT-PCR. B-D. MSCs were transfected for 1 
day with SOX9-AS1 or ROCR-targetting or non-targetting control siRNA prior to chondrogenic 
differentiation in a V-bottom 96 well plate for up to 24 hrs. RNA and protein was extracted and 
expression of SOX9 (B) mRNA or (C) protein measured by real-time RT-PCR or immunoblotting. D. 
Expression of L-SOX5a and SOX6. Values are the mean ± SEM of data pooled from (A) 3 MSC donors; 
(B-D) 4 MSC donors. ∗ = P < 0.05; ∗∗ = P < 0.01; ∗∗∗ = P < 0.001 for lncRNA siRNA versus non-targetting 
siRNA. Significant differences between sample groups were assessed by one-way analysis of variance 
followed by the Bonferroni post hoc test for multiple comparisons or a two-tailed Students t-test was 
performed for single comparisons. 
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 Figure 5. Effect of lncRNA depletion on MSC osteoblastogenic and adipogenic differentiation 
A-C. MSCs were transfected for 2 days with SOX9-AS1 or ROCR-targetting or non-targetting control 
siRNA prior to osteoblastogenic differentiation. A. Representative matrix mineralisation assayed by 
alizarin red staining after 21 days. B. Quantification of A. C. RNA was extracted and expression of the 
indicated genes at Day 7 measured by real-time RT-PCR. D-F. MSCs were transfected for 2 days with 
SOX9-AS1 or ROCR-targetting or non-targetting control siRNA prior to adipogenic differentiation. D. 
Representative fat droplet generation assayed by oil red staining after 14 days. E. Quantification of D. 
F. RNA was extracted and expression of the indicated genes at Day 7 measured by real-time RT-PCR. 
Values are the mean ± SEM of data pooled from 4 MSC donors. ∗ = P < 0.05; ∗∗∗ = P < 0.001 for lncRNA 
siRNA versus non-targetting siRNA. Significant differences between sample groups were assessed by 
one-way analysis of variance followed by the Bonferroni post hoc test for multiple comparisons or a 
two-tailed Students t-test was performed for single comparisons. 
  
D
ev
el
o
pm
en
t •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
 Figure 6. Effect of SOX9 overexpression in combination with ROCR depletion on MSC chondrogenic 
differentiation and gene expression 
MSCs were transduced with SOX9 or control lentivirus (pCDH) for 1 day then transfected for 1 day 
with ROCR-targetting or non-targetting control siRNA prior to chondrogenic differentiation in a V-
bottom 96 well plate. A. Expression of SOX9 in only non-targetting control siRNA pellets at Day 3. B. 
GAG levels assayed by DMB assay in only non-targetting control siRNA pellets at Day 7. C. Expression 
of SOX9 at Day 3. D. GAG levels assayed by DMB assay at Day 7. E-F. Expression of the indicated genes 
at Day 3. C-F. Expression is presented as a percentage of non-targetting control levels for cells 
transduced with each virus. Values are the mean ± SEM of data pooled from 4 MSC donors. ∗ = P < 
0.05; ∗∗ = P < 0.01; ∗∗∗ = P < 0.001 for lncRNA siRNA versus non-targetting siRNA, or for SOX9 versus 
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control lentivirus where indicated above the chart. Significant differences between sample groups 
were assessed by one-way analysis of variance followed by the Bonferroni post hoc test for multiple 
comparisons or a two-tailed Students t-test was performed for single comparisons. 
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>ROCR transcript variant 1 (LOC102723505, ENST00000430908, AC005152.3)
AGCCTTTTAAGACACATGTTTTGGAATACAGTCAAATGCGTGCTGCTGTATGACCAGCCTATTTGAACTA
CTTAAGCATCAACTAATTAATCTGCAAGTGAAGAATACTTCCAGCATTACTCTATAATTAGACAATCTCAG
GAGGAAACAAGAGGATTTCAAAGGGGAGTCAGATGGTTTCGCAGACCGCTACATCATTTATTTTTTCATC
ACTCAGATTATGCCTCCAAATCCTACAGAAGTATAACAACCATAGAACAGACAAACACCAACAGCATCAA
CAACAGAGAAACTCAGTCCAGGAGGATATGAAACCCTTTGTAATAAAGAAAGCAACATCCATGAA
>ROCR transcript variant 2
AGTCCTTGAGGGACAAGAAAGTGGAGCCCAGGACTTTCCAGTCCCCACCTAGTGATCAACGTCTCACCC
ACGGTCAGGGGAGCAACTGGTGGTTCTACTTTTTTGAATTCTGAAGGCAAAGGCAAGCTTTTTTTAGGG
GTCCTGCTGTTGGCAGAGAAAGCTCCCAAGAGTTCTGCAGAGAAGAAGGATATAGACTCCAAAATTTTA
CTTCCAGGGACCATTTCAGTAGAGCCTTTTAAGACACATGTTTTGGAATACAGTCAAATGCGTGCTGCTG
TATGACCAGCCTATTTGAACTACTTAAGCATCAACTAATTAATCTGCAAGTGAAGAATACTTCCAGCATTA
CTCTATAATTAGACAATCTCAGGAGGAAACAAGAGGATTTCAAAGGGGAGTCAGATGGTTTCGCAGACC
GCTACATCATTTATTTTTTCATCACTCAGATTATGCCTCCAAATCCTACAGAAGTATAACAACCATAGAAC
AGACAAACACCAACAGCATCAACAACAGAGAAACTCAGTCCAGGAGGATATGAAACCCTTTGTAATAAA
GAAAGCAACATCCATGA
>ROCR transcript variant 3
CAGCGGTTGATTGCGAGGAGCAGCGGAAGGAAGGATGTATCAAACCGAAAGAAGAAAGAACCCCTGC
CAGTCGCCCCCATGACATCCGACTCTGAACGGCAGCGATCTAGAGGCTGCGGCGTGTTGCAGATTAACA
GCAGCGAGGGCAGGAGGCAAATCAGATGCCGCAGGAGCTGACTGTTTTCTTTAGCCCTGAGAGCTGAC
TGTAGGCACAGGTTGCATATCAAAGGCAACGGGAATCAGTCTGTGGCAATATTACATCAGGGACCATTT
CAGTAGAGCCTTTTAAGACACATGTTTTGGAATACAGTCAAATGCGTGCTGCTGTATGACCAGCCTATTT
GAACTACTTAAGCATCAACTAATTAATCTGCAAGTGAAGAATACTTCCAGCATTACTCTATAATTAGACAA
TCTCAGGAGGAAACAAGAGGATTTCAAAGGGGAGTCAGATGGTTTCGCAGACCGCTACATCATTTATTT
TTTCATCACTCAGATTATGCCTCCAAATCCTACAGAAGTATAACAACCATAGAACAGACAAACACCAACA
GCATCAACAACAGAGAAACTCAGTCCAGGAGGATATGAAACCCTTTGTAATAAAGAAAGCAACATCCAT
GA
MSC ROCR
Cartilage ROCR
A.
B.
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Supplementary Figure 1. 
A. Transcript sequences of ROCR variants identified by RNA-Seq and RACE. Exons are 
delineated by the change between black and grey nucleotides. Primer locations are indicated 
by underlining (blue for exon1-2 assay, red for exon2-3 assay). B. Genome browser schematic 
of the two 4 exon transcript variants of ROCR with alternative first exons as indicated by 
5’RACE from cartilage and MSC RNA. 
Development 144: doi:10.1242/dev.152504: Supplementary information
D
ev
el
o
pm
en
t •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
A.
B.
Supplementary Figure 2
Development 144: doi:10.1242/dev.152504: Supplementary information
D
ev
el
o
pm
en
t •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
Supplementary Figure 2. 
UCSC genome browser schematic of cartilage RNA-Seq reads aligned to the human genome 
with evidence of transcript start and end sites using CAGE (cap analysis gene expression) and 
PolyA-Seq data. A. SOX9 and upstream locus. B. ROCR locus. 
Development 144: doi:10.1242/dev.152504: Supplementary information
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ORFfinder
Start Stop Length (nt | aa)
ENST00004309
08
50 127 78 | 25
ROCR_HAC 279 356 78 | 25
ROCR_MSC 79 177 99 | 32
329 406 78 | 25
SOX9-AS1 483 776 294 | 97
2739 2930 192 | 63
837 1001 165 | 54
1511 1672 162 | 53
125 280 156 | 51
1393 1521 129 | 42
76 201 126 | 41
2295 2408 114 | 37
2100 2204 105 | 34
2137 2238 102 | 33
256 351 96 | 31
1908 1988 81 | 26
589 666 78 | 25
LINC01152 2605 2757 153 | 50
2571 2711 141 | 46
1048 1179 132 | 43
1182 1304 123 | 40
1967 2086 120 | 39
320 430 111 | 36
286 390 105 | 34
2460 2546 87 | 28
861 944 84 | 27
2251 2334 84 | 27
1124 1201 78 | 25
2803 2880 78 | 25
SOX9 373 1902 1530 | 509
1241 1519 279 | 92
3334 3564 231 | 76
2668 2862 195 | 64
2161 2322 162 | 53
2859 2996 138 | 45
2099 2227 129 | 42
1927 2049 123 | 40
2936 3037 102 | 33
3256 3333 78 | 25
CPAT CPC
Sequence Name
RNA 
Size
Fickett 
Score
Hexamer 
Score
Coding 
Probability
Coding 
Label
CODING POTENTIAL 
SCORE C/NC
ENST000004309
08 346 0.7649 -0.081 0.012 no -1.285 noncoding
ROCR_HAC 574 0.7649 -0.081 0.012 no -0.758
noncoding 
(weak)
ROCR_MSC 624 0.7649 -0.081 0.012 no -1.332 noncoding
SOX9-AS1 3032 1.0343 -0.010 0.128 no -1.018 noncoding
LINC01152 3578 0.9027 -0.053 0.015 no 0.364 coding (weak)
SOX9 3963 1.3018 0.647 1.000 yes 8.199 coding
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Supplementary Figure 3. 
In silico analysis indicates a lack of coding potential for both SOX9-AS1 and ROCR, with the 
existence of A. only very short open reading frames (ORF Finder) and B-D. codon substitution 
rates indicative of noncoding transcripts. B. CPAT and CPC. C. PhyloCSF on SOX9 and SOX9-
AS1 locus. D. PhyloCSF on ROCR locus. 
Development 144: doi:10.1242/dev.152504: Supplementary information
D
ev
el
o
pm
en
t •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
SOX9
A
di
po
se
A
rt
ic
ul
ar
 C
ar
til
ag
e
B
la
dd
er
B
ra
in
C
er
vi
x
C
ol
on
E
so
ph
ag
us
H
ea
rt
K
id
ne
y
Li
ve
r
Lu
ng
O
va
ry
P
la
ce
nt
a
S
ke
le
ta
l M
us
cl
e
S
m
al
l I
nt
es
tin
e
S
pl
ee
n
Te
st
es
Th
ym
us
Th
yr
oi
d
Tr
ac
he
a
0.0001
0.001
0.01
0.1
1
10
100
G
e
n
e
 /
 H
P
R
T
1
HPRT1
A
di
po
se
A
rt
ic
ul
ar
 C
ar
til
ag
e
B
la
dd
er
B
ra
in
C
er
vi
x
C
ol
on
E
so
ph
ag
us
H
ea
rt
K
id
ne
y
Li
ve
r
Lu
ng
O
va
ry
P
la
ce
nt
a
S
ke
le
ta
l M
us
cl
e
S
m
al
l I
nt
es
tin
e
S
pl
ee
n
Te
st
es
Th
ym
us
Th
yr
oi
d
Tr
ac
he
a
0
10
20
30
40
C
T
s
COL2A1
A
di
po
se
A
rt
ic
ul
ar
 C
ar
til
ag
e
B
la
dd
er
B
ra
in
C
er
vi
x
C
ol
on
E
so
ph
ag
us
H
ea
rt
K
id
ne
y
Li
ve
r
Lu
ng
O
va
ry
P
la
ce
nt
a
S
ke
le
ta
l M
us
cl
e
S
m
al
l I
nt
es
tin
e
S
pl
ee
n
Te
st
es
Th
ym
us
Th
yr
oi
d
Tr
ac
he
a
0.0001
0.001
0.01
0.1
1
10
100
G
e
n
e
 /
 H
P
R
T
1
A.
B.
C.
Supplementary Figure 4
Development 144: doi:10.1242/dev.152504: Supplementary information
D
ev
el
o
pm
en
t •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
Supplementary Figure 4. 
Expression of A. SOX9, B. COL2A1 and C. HPRT1 in an RNA tissue panel measured by real-
time RT-PCR. Values are the technical mean of data pooled from 3 donors per tissue. 
Development 144: doi:10.1242/dev.152504: Supplementary information
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Supplementary Figure 5
Supplementary Figure 5. 
MSCs were transfected for 1 day with ROCR-targetting or non-targetting control GapmeR prior 
to chondrogenic differentiation in a V-bottom 96 well plate.  A. ROCR expression in RNA 
extracted from Day 0, 1 and 3 chondrogenic pellets. Expression is presented as a percentage of 
non-targetting control levels. B. GAG levels assayed by DMB assay in Day 7 chondrogenic 
pellets. C-E. Expression of (C) SOX9, (D) COL2A1, (E) ACAN in RNA extracted from Day 0, 
1 and 3 chondrogenic pellets. Values are the mean ± SEM of data pooled from 4 MSC donors. 
∗∗∗ = P < 0.001 for ROCR GapmeR versus non-targetting GapmeR. 
Development 144: doi:10.1242/dev.152504: Supplementary information
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Supplementary Figure 6. 
A. MSC were transduced for 2 days with ROCR-expressing lentivirus particles (transcript 
variant 2 and 3) prior to chondrogenic differentiation for up to 7 days. Expression of ROCR, 
SOX9, COL2A1 and ACAN in RNA extracted from Day 0, 1, 3 and 7 chondrogenic pellets. 
Values are the mean ± SEM of data pooled from 2 MSC donors. B. ROCR and SOX9 expression 
in HAC transduced with ROCR-expressing lentivirus particles (transcript variant 2 and 3) for 
3 days. Values are the mean ± SEM of data pooled from 2 OA HAC donors. 
Development 144: doi:10.1242/dev.152504: Supplementary information
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Supplementary Figure 7. 
A. SOX9 and ROCR expression in HAC transfected for 2 days with the indicated siRNAs. 
Values are the mean ± SEM of data pooled from 4 OA HAC donors. ∗∗∗ = P < 0.001. B. ROCR 
expression in MSCs transduced with SOX9 or control lentivirus (pCDH) for 2 days. Values 
are the mean ± SEM of data pooled from 4 MSC donors. 
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Supplementary Figure 8. 
A. Blastn result of homology search for ROCR sequence in mouse. B. UCSC genome browser 
schematic of the ROCR locus showing vertebrate conservation. C. Expression of Bc006965, 
Sox9 and Col2a1 in C57BL/6 mouse xiphoid cartilage RNA. 
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Supplementary Figure 9
Supplementary Figure 9. 
MSCs were transfected for 2 days with ROCR-targetting or non-targetting control siRNA prior 
to chondrogenic differentiation in a V-bottom 96 well plate or maintenance in MSC medium 
for up to 7 days. Media were collected immediately prior to the induction of chondrogenesis 
(Day 0) and after 3 and 7 days. Cytotoxicity was measured with the use of the Promega 
CytoTox 96 kit.  
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Primer Sequence Probe
SOX9-AS1 exon4-5 F ccatgagcatttctcgtctg 65
SOX9-AS1 exon4-5 R caggacaaggtggatgaaca
SOX9-AS1 exon5-6 F ctggcaagaggcaggaaa 38
SOX9-AS1 exon5-6 R gctctcatccaaggtgaacag
ROCR exon2-3 F tgctgtatgaccagcctatttg 11
ROCR exon2-3 R tcctcttgtttcctcctgaga
ROCR exon1-2 F ctgaaggcaaaggcaagc 18
ROCR exon1-2 R caaaacatgtgtcttaaaaggctct
LINC01152 F cctcacttcctcctcttcctg 19
LINC01152 R ccccatctcatctgtttttga
RUNX2 F gtgcctaggcgcatttca 29
RUNX2 R gctcttcttactgagagtggaagg
ALPL F agaaccccaaaggcttcttc 31
ALPL R cttggcttttccttcatggt
ADIPOQ F ggtgagaagggtgagaaagga 85
ADIPOQ R tttcaccgatgtctcccttag
FABP4 F ccaccataaagagaaaacgagag 31
FABP4 R gtggaagtgacgcctttcat
L-SOX5a F tttacctcaggagtttgaaagga 38
L-SOX5a R gcttgtcaccatggctacct
SOX6 F gcttctggactcagcccttta 67
SOX6 R ggccctttagcctttggtta
ROCR RACE GSP1 TTTGAAATCCTCTTGTTTC
ROCR RACE GSP2 CAAAACATGTGTCTTAAAAGGCTCT
siRNA Target sequence
siSOX9-AS1 CAAAGGAGCTAAAGAAGAA
siROCR-1 GGAGGAAACAAGAGGATTT
siROCR-2 CAACCATAGAACAGACAAA
GapmeR Target sequence
GapROCR ACTTAAGCATCAACTA
Supplementary Table 1. 
Primer and siRNA/GapmeR sequences. 
Development 144: doi:10.1242/dev.152504: Supplementary information
D
ev
el
o
pm
en
t •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
Supplementary Table 2. 
Cartilage RNA-Seq lncRNA expression and SOX9 expression. 
Supplementary Table 3. 
Expression of ROCR and SOX9-AS1 in cell types from Human Protein Atlas and Illumina 
BodyMap RNA-Seq data. 
Click here to Download Table S2
Click here to Download Table S3
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